1-877-CSI-0360

International Find A Doctor Contact Us Bioskills Lab Careers With Us

Product
Solutions
- Product Solutions
  For Healthcare
  Professionals
  
  At CSI, we are leading the way to help successfully treat arterial calcium by creating devices designed to restore blood flow and reduce calcium.
  
  US Peripheral Interventions
  US Peripheral Interventions
  US Coronary Interventions
  US Coronary Interventions
  International
  International
Healthcare
Professionals
- Healthcare
  Professionals
  
  Collaborating with leading experts to develop solutions to treat patients with advanced PAD and CAD.
  
  Physicians
  Physicians
  Fellows
  Fellows
  Cath Lab Team
  Cath Lab Team
  Hospital Administration
  Hospital Administration
  Clinical Evidence
  Clinical Evidence
  Case Studies
  Case Studies
  Healthcare Economics & Outcomes Research
  Healthcare Economics & Outcomes Research
  Reimbursement & Coding
  Reimbursement & Coding
  Conference Hub
  Conference Hub
  CSIQ^® Learn
  CSIQ^® Learn
  Office-Based Labs
  Office-Based Labs
Patient
Resources
- Patient
  Resources
  
  When you or a loved one is diagnosed with advanced CAD or PAD and include blockages made of calcium, you're looking for solutions. CSI is committed to getting people back to what matters.
  
  Peripheral Artery Disease (PAD)
  Peripheral Artery Disease (PAD)
  
  PAD is a potentially life-threatening disease where plaque, like calcium, builds up along blood vessel walls, narrowing the arteries and reducing blood flow to the legs and feet.
  
  Coronary Artery Disease (CAD)
  Coronary Artery Disease (CAD)
  
  Often referred to as blocked arteries, CAD is the most common heart disease and can cause shortness of breath, chest pain or a heart attack.
  
  Find a Doctor
  Find a Doctor
  
  Use our locator to find a doctor who is experienced using Cardiovascular Systems, Inc.'s (CSI) device to treat appropriate patients with PAD or CAD.
  
  PAD Patient Stories
  PAD Patient Stories
  CAD Patient Stories
  CAD Patient Stories
  Enter Your Zip Code
  Enter Your Zip Code
Investor
Relations
- Investor Relations
  
  Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating coronary and peripheral artery disease.
  
  Financial Events
  Financial Events
  
  Review SEC Filings, Financial Reports and Proxy Information.
  
  News Releases
  News Releases
  
  View our latest news, including financial announcements, clinical research results and product approvals and launches.
  
  Presentations
  Presentations
  
  Find information for investor presentations & earnings conference calls.
  
  Stock Information
  Stock Information
  
  Review current stock price, stock chart and analyst coverage.
  
  Stock Quote
  
  NASDAQ: CSII
  19.84
  +0.07 ( 0.35% )
  
  03/24/2023 16:00:00
  (Minimum 20 minutes delay)
About
CSI
- About CSI
  
  We are devoted to developing innovative solutions for treating peripheral and coronary artery disease, to help physicians conquer calcium, one of the largest challenges when treating PAD and CAD and help patients get back to what matters.
  
  Learn More
  Learn More
  
  Find out more about CSI, our company history, our solutions and the ways you can join in our efforts.
  
  Leadership
  Leadership
  
  The ability to serve the cardiovascular market with state-of-the-art medical technology begins with leaders.
  
  Careers
  Careers
  
  Learn more about what it's like to work at CSI, view open positions and apply.
  
  Media Resources
  Media Resources
  
  View our media kit and press releases, including financial announcements and clinical research results.
  
  Corporate Governance
  Corporate Governance
  
  Review our governance documents, principles of corporate governance and code of ethics and business conduct.
  
  Compliance
  Compliance
  
  Read about our company policies, monitoring, public disclosures and other details.

360 Economic Evidence-02

For more information about product availability globally, please click below.

OrbusNeich Medical Co. Ltd.:

→APAC (Asia-Pacific)
→EMEA (Europe, Middle East, Africa)

ON has exclusive distribution rights in the following countries: Czech Republic, Slovakia, Egypt, Hong Kong, Italy, Kingdom of Saudi Arabia, Kuwait, Malaysia, Singapore, Spain, Switzerland, and United Arab Emirates; ON has non-exclusive distribution rights in Austria, France, Germany, and the Netherlands.

Medikit Co., Ltd:

→Japan

In November 2016, Cardiovascular Systems, Inc. (CSI) announced that Medikit, Co., Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Japan.

PT. Revass Utama Medika:

→Indonesia

In February 2021, Cardiovascular Systems, Inc. (CSI) announced that PT. Revass Utama Medika signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Indonesia.

Bio-Excel (Australia) Pty. Ltd.:

→Australia

In March 2021, Cardiovascular Systems, Inc. (CSI) announced that Bio-Excel Co. Ltd. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Australia.

RSK Medical Inc.

→Canada

In April 2021, Cardiovascular Systems, Inc. (CSI) announced that RSK Medical Inc. signed an exclusive sales agent agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Canada.

CardiRad Group

→Nordics

In August 2021, Cardiovascular Systems, Inc. (CSI) announced that CardiRad Group signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Finland, Sweden, Norway and Denmark.

ProCardia Medical Sp. z o. o.

→Poland

In September 2021, Cardiovascular Systems, Inc. (CSI) announced that ProCardia Medical Sp. z o. o. signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Poland.

Vascular Perspectives Ltd.

→U.K.

In August 2021, Cardiovascular Systems, Inc. (CSI) announced that Vascular Perspectives Ltd. signed an exclusive sales agent agreement to sell its coronary and peripheral Orbital Atherectomy Systems in U.K.

SISK Healthcare/Synapse Medical

→Ireland

In September 2021, Cardiovascular Systems, Inc. (CSI) announced that SISK Healthcare UC Trading as Synapse Medical signed an exclusive distribution agreement to sell its coronary and peripheral Orbital Atherectomy Systems in Ireland.

1-877-CSI-0360

Product Solutions For Healthcare Professionals

US Peripheral Interventions

US Peripheral Interventions

US Coronary Interventions

US Coronary Interventions

International

International

Healthcare Professionals

Physicians

Physicians

Fellows

Fellows

Cath Lab Team

Cath Lab Team

Hospital Administration

Hospital Administration

Clinical Evidence

Clinical Evidence

Case Studies

Case Studies

Healthcare Economics & Outcomes Research

Healthcare Economics & Outcomes Research

Reimbursement & Coding

Reimbursement & Coding

Conference Hub

Conference Hub

CSIQ® Learn

CSIQ® Learn

Office-Based Labs

Office-Based Labs

Patient Resources

Peripheral Artery Disease (PAD)

Peripheral Artery Disease (PAD)

Coronary Artery Disease (CAD)

Coronary Artery Disease (CAD)

Find a Doctor

Find a Doctor

PAD Patient Stories

PAD Patient Stories

CAD Patient Stories

CAD Patient Stories

Enter Your Zip Code

Enter Your Zip Code

Investor Relations

Financial Events

Financial Events

News Releases

News Releases

Presentations

Presentations

Stock Information

Stock Information

Stock Quote

03/24/2023 16:00:00 (Minimum 20 minutes delay)

About CSI

Learn More

Learn More

Leadership

Leadership

Careers

Careers

Media Resources

Media Resources

Corporate Governance

Corporate Governance

Compliance

Compliance

360 Economic Evidence-02

Product Solutions
For Healthcare
Professionals

Healthcare
Professionals

CSIQ^® Learn

CSIQ^® Learn

Patient
Resources

03/24/2023 16:00:00
(Minimum 20 minutes delay)